Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:33:36.517Z.
Calculation as of: 2026-10-06T20:33:36.517Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a8ce9bd0ffb1cb5d8a686ad50c5c0fc76176a0385911c5cc34bdb5d73fbb2f35
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Yarrow Bioscience Inc
Market Cap
$174.27M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.76M
Operating Cash Flow Yield
N/A
TTM Avg
6.78%
3Y Avg
6.78%
5Y Avg
6.78%
Market Cap
$172.42M
Operating Cash Flow Yield
18.54%
TTM Avg
12.15%
3Y Avg
6.20%
5Y Avg
6.85%
Market Cap
$171.13M
Operating Cash Flow Yield
N/A
TTM Avg
0.62%
3Y Avg
0.62%
5Y Avg
0.62%
Market Cap
$169.53M
Operating Cash Flow Yield
N/A
TTM Avg
11.12%
3Y Avg
9.89%
5Y Avg
9.89%
Market Cap
$179.26M
Operating Cash Flow Yield
N/A
TTM Avg
4.81%
3Y Avg
4.81%
5Y Avg
4.81%
Market Cap
$168.92M
Operating Cash Flow Yield
N/A
TTM Avg
13.87%
3Y Avg
13.87%
5Y Avg
13.87%
Market Cap
$179.75M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$168.10M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Yarrow Bioscience Inc (YARW) | $174.27M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | N/A | 6.78% | 6.78% | 6.78% |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | 18.54% | 12.15% | 6.20% | 6.85% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | N/A | 0.62% | 0.62% | 0.62% |
| Journey Medical Corporation (DERM)vs › | $169.53M | N/A | 11.12% | 9.89% | 9.89% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | N/A | 4.81% | 4.81% | 4.81% |
| MediWound Ltd. (MDWD)vs › | $168.92M | N/A | 13.87% | 13.87% | 13.87% |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
